Clinical Trial Update: Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and efficacy of ranibizumab in patients with choroidal neovascularization due to causes other than age-related macu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Retinal Pigment Epithelium Detachment

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: University of Melbourne | Conditions: Choroidal Neovascularization, Retinal Pigment Epithelial Detachment | Phase 4 | Status: COMPLETED